# OurCrowd

> OurCrowd is a VC fund backing Software and Artificial Intelligence. See 309 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Jerusalem, Israel
- Total investments: 309
- Last investment: Aug 2026
- Lead investor: 16%
- Last fund: Sep 2023
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/company/ourcrowd-llc
- X (Twitter): https://twitter.com/OurCrowd
- Website: http://www.ourcrowd.com
- Facebook: http://www.facebook.com/Ourcrowdfund

OurCrowd is a venture investing platform that enables institutions and individuals to invest and engage in emerging companies. OurCrowd was started in 2013, driven by the idea that the business of building startups grows bigger and better when the global 'crowd' gains access to VC-level investment opportunities.

## Contacts

5 contacts available for OurCrowd. Shizune tracks 19 team members at OurCrowd. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/ourcrowd?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $593k–$10M |
| Series A | $5.3M–$34M |
| Series B | $8M–$65M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 35 | 11% |
| Artificial Intelligence | 34 | 11% |
| Health Care | 22 | 7% |
| Machine Learning | 22 | 7% |
| Biotechnology | 19 | 6% |

232 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 58 | 19% |
| Series A | 45 | 15% |
| Seed | 35 | 11% |
| Series C | 28 | 9% |
| Funding Round | 28 | 9% |

15 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Israel | 93 | 30% |
| United States | 59 | 19% |
| New Zealand | 5 | 2% |
| Canada | 4 | 1% |
| Singapore | 3 | 1% |

13 countries tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| David Shore | Vice President, Investor Relations - Canada | 0 | https://shizune.co/investors/profile/david-shore-2 |
| Denes Ban | Managing Director, Partner | 4 | https://shizune.co/investors/profile/denes-ban |
| Etai Kramer | Managing Director, Head Funds | 1 | https://shizune.co/investors/profile/etai-kramer |
| Lenny Roth | Partner | 0 | https://shizune.co/investors/profile/lenny-roth |
| Ron Moritz | Venture Partner, Cybersecurity | 3 | https://shizune.co/investors/profile/ron-moritz |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| N.Light | N.Light is a Metaverse 3D design software that allows individuals to effortlessly turn their ideas into reality. | $10.6M | Venture - Series Unknown | Aug 10, 2026 |  |
| Hemispheric | Hemispheric develops fundamental AI technologies aimed at deciphering brain activity for innovative applications. | $52M | Series A | Jul 15, 2026 |  |
| Corgi Insurance | Corgi Insurance Services, Inc. ("Corgi") is an American technology company that operates an artificial intelligence (AI)-powered insurance carrier based in San Francisco, California. Corgi Insurance develops and operates a fully integrated insurance stack using AI agents to automate traditional carrier operations, becoming the world’sfirst “AI insurance company.” The company owns multiple subsidiaries operating under a dog-themed naming convention. | $160M | Series B | May 06, 2026 |  |
| PhenOlives | PhenOlives transforms olive oil waste into nutritious, gluten-free olive flour that retains the health benefits of olive oil. The company employs a patented process to create a high-fiber ingredient suitable for various baking and cooking applications. | $270K | Seed | May 04, 2026 |  |
| Xage Security | Xage Security is an information technology company that offers blockchain-protected security platform for Industrial IoT. | $15M | Venture - Series Unknown | Mar 18, 2026 |  |
| WINN.AI | Winn.AI handles all of your sales busywork so you can type less and win more. | $18M | Series A | Feb 11, 2026 |  |
| Omnix Medical | Omnix Medical is dedicated to the development and commercialization of highly effective antibiotic agents against resistant pathogenic bacterial strains. Omnix is addressing an enormous and rapidly growing threat to public health, represented by millions worldwide, who suffer from infections associated with resistant bacteria. Omnix’s technologywill tilt the odds in the battle against resistant bacteria and improve the lives of many people worldwide. | $25M | Series C | Oct 15, 2025 |  |
| Leo AI | Leo™ is the world's first engineering design copilot, empowering engineers and designers to turn ideas into products in seconds. Leo's generative AI platform transforms text, sketches, specs, and CAD constraints into DFMA-optimized, full-assembly 3D CAD models, saving companies up to 70% of their engineering time and cost. Leading AIresearchers and mechanical engineers from MIT, Technion, Microsoft, and Elbit Systems founded Leo in 2023. | $5M | Seed | Sep 02, 2025 |  |
| RepAir | RepAir develops a Direct Air Capture system based on a proprietary electrochemical cell technology that can capture CO2 from the air in gigaton scale. Powered solely by renewable energy, our system can be deployed at the site of carbon storage or utilizations, saving arable land and avoiding CO2 transport. | $15M | Series A | Apr 24, 2025 |  |
| BioLumic | BioLumic develops light signals that activate plant growth and unlock the natural genetic potential of crops. The company's photogenics platform leverages innovation in plant science, light technology and genetic insights. Demonstrated results include higher yield, improved vigor, increased disease and pest resistance, and improvements incrops composition. These results have been across a variety of seeds and seedling: soybean, cannabis and vegetable and fruit crops. It is a clean technology that does not require the use of chemicals or amendments. BioLumic is a private company and was founded in 2013. | $8.3M | Series B | Apr 22, 2025 |  |

10 of 309 investments shown.

## Co-investors
- [Finistere Ventures](https://shizune.co/investors/profile/finistere-ventures) — VC Fund, 21 deals together
- [Jerusalem Venture Partners (JVP)](https://shizune.co/investors/profile/jerusalem-venture-partners) — VC Fund, 13 deals together
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund, 11 deals together
- [Pitango VC](https://shizune.co/investors/profile/pitango-venture-capital) — VC Fund, 11 deals together
- [iAngels](https://shizune.co/investors/profile/iangels) — VC Fund, 10 deals together
- [Next Gear Ventures](https://shizune.co/investors/profile/nextgear-ventures) — VC Fund, 10 deals together

## Similar investors

### Similar industry
- [SVG Ventures](https://shizune.co/investors/profile/svg-ventures) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Omnivore](https://shizune.co/investors/profile/omnivore-partners) — VC Fund

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

### Similar country
- [F6 Ventures](https://shizune.co/investors/profile/flat6labs) — VC Fund
- [Oqal](https://shizune.co/investors/profile/oqal) — VC Fund
- [Alesta Yatırım](https://shizune.co/investors/profile/alesta-girisim) — VC Fund

## Featured in investor lists
- [All Investors in Middle East](https://shizune.co/investors/investors-middle-east)
- [All VC Funds in Middle East](https://shizune.co/investors/vc-funds-middle-east)
- [All Investors in Israel](https://shizune.co/investors/investors-israel)
- [All VC Funds in Israel](https://shizune.co/investors/vc-funds-israel)
- [SaaS Investors in Middle East](https://shizune.co/investors/saas-investors-middle-east)
- [SaaS VC Funds in Middle East](https://shizune.co/investors/saas-vc-funds-middle-east)

## FAQ

### What does OurCrowd invest in?

OurCrowd invests primarily in Software, Artificial Intelligence and Health Care startups, most often at Series B and Series A stage. Most of the 309 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is OurCrowd's check size?

OurCrowd typically joins rounds of $593k–$10M at Seed, $5.3M–$34M at Series A and $8M–$65M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds OurCrowd participates in.

### How do I contact OurCrowd?

Public channels for OurCrowd include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at OurCrowd?

The team at OurCrowd includes David Shore (Vice President, Investor Relations - Canada), Denes Ban (Managing Director, Partner) and Etai Kramer (Managing Director, Head Funds), among 19 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co